Skip to content

Study for comparison between membrane materials on survival in super high flux hemodialysis and online hemodiafiltration

Retrospective clinical study for comparison between membrane materials on survival in super high flux hemodialysis and online hemodiafiltration - Prognosis verification of membrane materials in SHF-HD and OHDF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000051791
Enrollment
700
Registered
2024-03-31
Start date
2023-08-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with end-stage kidney disease undergoing super high flux hemodialysis and online hemodiafiltration

Interventions

None listed

Sponsors

Social medical corporation, Kawashimakai, Kawashima hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients on maintenance hemodialysis and online hemodiafiltration as of July 1, 2017

Exclusion criteria

Exclusion criteria: 1. Under 20 years of age 2. Dialysis conditions between April 1, 2017 and June 30, 2017, which are different from those as of July 1, 2017 3. Blood purification methods other than hemodialysis and online hemodiafiltration 4. Dialysis frequency below 3 sessions/week or dialysis time below 3 hours/session 5. Pregnant or lactating patients 6. Missing data for covariates at study entry 7. Dialyzers with beta2 microgloburln clearance below 70 mL/min 8. Dialyzers and hemodiafilters less than 50 number of each membrane material

Design outcomes

Primary

MeasureTime frame
3-year all-cause mortality

Secondary

MeasureTime frame
Estimated albumin leakage

Countries

Japan

Contacts

Public ContactManabu Tashiro

Social medical corporation, Kawashimakai, Kawashima hospital Department of Nephrology

m.tashiro@khg.or.jp81-88-631-0110

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026